Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis

CJ Stock, H Sato, C Fonseca, WAS Banya… - Thorax, 2013 - thorax.bmj.com
Background A polymorphism (rs35705950) 3 kb upstream of MUC5B, the gene encoding
Mucin 5 subtype B, has been shown to be associated with familial and sporadic idiopathic …

[HTML][HTML] Telomeres in interstitial lung disease

CJW Stock, EA Renzoni - Journal of clinical medicine, 2021 - mdpi.com
Interstitial lung diseases (ILD) encompass a group of conditions involving fibrosis and/or
inflammation of the pulmonary parenchyma. Telomeres are repetitive DNA sequences at …

[HTML][HTML] A Polymorphism in the CTGF Promoter Region Associated with Systemic Sclerosis

…, P Leoni, N McHugh, CJ Stock… - … England Journal of …, 2007 - Mass Medical Soc
Background Systemic sclerosis (scleroderma) is a life-threatening autoimmune disease that
is characterized by the presence of specific autoantibodies and fibrosis of the skin and major …

Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised …

…, C Boccabella, A De Lauretis, CJW Stock… - The Lancet …, 2018 - thelancet.com
Background In fibrotic interstitial lung diseases, exertional breathlessness is strongly linked
to health-related quality of life (HRQOL). Breathlessness is often associated with oxygen …

Host–microbial interactions in idiopathic pulmonary fibrosis

…, A Blanchard, LM Edwards, C Stock… - American journal of …, 2017 - atsjournals.org
Rationale: Changes in the respiratory microbiome are associated with disease progression
in idiopathic pulmonary fibrosis (IPF). The role of the host response to the respiratory …

[HTML][HTML] Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease

GE Lindahl, CJW Stock, X Shi-Wen, P Leoni… - Respiratory …, 2013 - Springer
Background Interstitial lung disease is a major cause of morbidity and mortality in systemic
sclerosis (SSc), with insufficiently effective treatment options. Progression of pulmonary …

[HTML][HTML] Novel IL10 gene family associations with systemic juvenile idiopathic arthritis

MS Fife, A Gutierrez, EM Ogilvie, CJW Stock… - Arthritis research & …, 2006 - Springer
Juvenile idiopathic arthritis (JIA) is the most common cause of chronic childhood disability
and encompasses a number of disease subgroups. In this study we have focused on systemic …

Serum markers of pulmonary epithelial damage in systemic sclerosis‐associated interstitial lung disease and disease progression

CJW Stock, RK Hoyles, C Daccord, M Kokosi… - …, 2021 - Wiley Online Library
Background and objective The course of systemic sclerosis‐associated interstitial lung
disease (SSc‐ILD) is highly variable, and accurate prognostic markers are needed. KL‐6 is a …

Genetic predictors of systemic sclerosis-associated interstitial lung disease: a review of recent literature

CJW Stock, EA Renzoni - European Journal of Human Genetics, 2018 - nature.com
The interplay between genetic and environmental factors is likely involved in the pathogenesis
of systemic sclerosis (SSc). Interstitial lung disease associated in the context of SSc (SSc-…

Interleukin-31 promotes pathogenic mechanisms underlying skin and lung fibrosis in scleroderma

…, S Morris, A Bowman, A Stainer, A Rice, C Stock… - …, 2020 - academic.oup.com
Objectives Cytokines released by infiltrating T cells may promote mechanisms leading to
fibrosis in scleroderma. The aim of this study was to investigate the role of the Th2 cytokine IL-…